Yes, genomics and epigenomics can be used to predict toxicity. By identifying genetic and epigenetic biomarkers, researchers can develop predictive models for assessing the risk of toxic exposure. This approach is particularly useful in personalized medicine, where individual genetic and epigenetic profiles can guide risk assessment and therapeutic interventions.
